Dr. Kauff, who joined the institute Aug. 14, previously served as director of clinical cancer genetics at the Duke Cancer Institute, part of Durham, N.C.-based Duke University Health System. He was director of the ovarian cancer screening and prevention program at New York City-based Memorial Sloan-Kettering Cancer Center.
Dr. Kauff is a fellow of the American College of Obstetrics and Gynecology and a member of the American Society of Clinical Oncology and the American Association for Cancer Research.
In his new role, Dr. Kauff will oversee the development and incorporation of cancer genetics, which includes genetic counseling for those with a predisposition to the disease, to improve cancer care at the health system.
More articles on executive moves:
4 recent hospital, health system CEO moves
CFO of Children’s Health in Dallas steps down; 2nd finance leader to leave in a month
Rush President Michael Dandorph to resign
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
